We have located links that may give you full text access.
GC-(4→8)-GCG, A Proanthocyanidin Dimer from Camellia ptilophylla, Modulates Obesity and Adipose Tissue Inflammation in High-fat Diet Induced Obese Mice.
Molecular Nutrition & Food Research 2019 March 21
SCOPE: Excessive fat accumulation in adipose tissue leads to obesity and related chronic inflammation. This study aimed to examine the effects of gallocatechin -(4→8)-gallocatechin-3-O-gallate (GC-(4→8)-GCG), a main proanthocyanidin dimer from Camellia ptilophylla (Cocoa tea), on adipocyte- and adipose-related inflammation in vivo and in vitro.
METHODS AND RESULTS: C57BL/6 mice were fed a high-fat diet (HFD) and GC-(4→8)-GCG (40 or 80 mg/kg/d) for 8 weeks. The metabolic profiles, adipose tissue hypertrophy, macrophage infiltration, and inflammatory cytokine production were investigated. Additionally, 3T3-L1 preadipocytes were utilized to investigate the effect of GC-(4→8)-GCG on preadipocyte differentiation and the tumor necrosis factor (TNF)-α-stimulated inflammatory response in vitro. GC-(4→8)-GCG supplementation decreased HFD-induced epididymal white adipose tissue (eWAT) hypertrophy, suppressed proinflammatory cytokine production and macrophage infiltration in eWAT, and improved insulin sensitivity in HFD-induced obese mice. In vitro, GC-(4→8)-GCG showed a strong anti-adipogenic potential in 3T3-L1 preadipocyte by inhibiting the expression of key adipogenic transcription factors and decreasing the production of proinflammatory cytokines by inhibiting the activation of the nuclear factor (NF)-κB, Janus tyrosine kinase/signal transducer and activator of transcription (JAK/STAT3) and mitogen-activated protein kinase (MAPK) signaling pathways.
CONCLUSION: GC-(4→8)-GCG could modulate obesity and improve obesity-related insulin resistance by inhibiting preadipocyte differentiation and the related proinflammatory responses. This article is protected by copyright. All rights reserved.
METHODS AND RESULTS: C57BL/6 mice were fed a high-fat diet (HFD) and GC-(4→8)-GCG (40 or 80 mg/kg/d) for 8 weeks. The metabolic profiles, adipose tissue hypertrophy, macrophage infiltration, and inflammatory cytokine production were investigated. Additionally, 3T3-L1 preadipocytes were utilized to investigate the effect of GC-(4→8)-GCG on preadipocyte differentiation and the tumor necrosis factor (TNF)-α-stimulated inflammatory response in vitro. GC-(4→8)-GCG supplementation decreased HFD-induced epididymal white adipose tissue (eWAT) hypertrophy, suppressed proinflammatory cytokine production and macrophage infiltration in eWAT, and improved insulin sensitivity in HFD-induced obese mice. In vitro, GC-(4→8)-GCG showed a strong anti-adipogenic potential in 3T3-L1 preadipocyte by inhibiting the expression of key adipogenic transcription factors and decreasing the production of proinflammatory cytokines by inhibiting the activation of the nuclear factor (NF)-κB, Janus tyrosine kinase/signal transducer and activator of transcription (JAK/STAT3) and mitogen-activated protein kinase (MAPK) signaling pathways.
CONCLUSION: GC-(4→8)-GCG could modulate obesity and improve obesity-related insulin resistance by inhibiting preadipocyte differentiation and the related proinflammatory responses. This article is protected by copyright. All rights reserved.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app